Clinical trials
Phase 4 Prostatic Hyperplasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
| Unknown status | 15 |
| Not yet recruiting | 7 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 7 |
| Mansoura University | 6 |
| Samsung Medical Center | 5 |
| Astellas Pharma Inc | 4 |
| Boehringer Ingelheim | 4 |
| Sanofi | 4 |
| Beni-Suef University | 3 |
| JW Pharmaceutical | 3 |
| Diskapi Yildirim Beyazit Education and Research Hospital | 2 |
| Mohsen Pourazizi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 94 |
| Lower Urinary Tract Symptoms | 16 |
| Urinary Bladder, Overactive | 9 |
| Prostatic Neoplasms | 3 |
| Hypogonadism | 2 |
| Iris Diseases | 2 |
| Nocturia | 2 |
| Pain | 2 |
| Urinary Bladder Neoplasms | 2 |
| Anemia | 1 |
Trials
Showing 51 to 75 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.